Season 2 (2021-2030)

Cardiovascular - Small Molecules (4)

Modality Indication Targets Stage Company Project No. Detail
1 Development of TNAP inhibitor, A new drug for medical treatment Aortic Stenosis
Small Molecules Aortic stenosis TNAP Hit REDNVIA Inc. RS-2023-00217370
2 Inhaler development with PDGFR small molecule inhibitors for pulmonary arterial hypertension
Small Molecules Pulmonary hypertension PDGFR Candidate Voronoi, Inc RS-2022-00165937
3 Phase II clinical development of DPP-4 inhibitor (Evogliptin), a new drug for medical treatment of Aortic Stenosis
Small Molecules Aortic Stenosis DPP-4 Phase 2 REDNVIA HN21C1047
4 Determining the efficacy and discovery of optimal lead compounds of a novel class of diuretics, pendrin inhibitors, for treatment of congestive heart failure and chronic kidney disease
Small Molecules Congestive heart failure, Chronic renal disease pendrin Lead Yonsei University HN21C0281
BACK